Close Menu X
Kelley & Ferraro, LLP
Free Consultations ~ Practicing Nationwide
216-202-3450 800-398-1795

Zantac Recall Archives

Zantac recall leads to federal investigation into drugmakers

Most people in Ohio and across the country believe that medication prescribed by their doctor or that they can buy over the counter is safe. After all, tests and approvals are needed before they can be put on the market. However, some drug manufacturers may not disclose important information about possible dangers, and as with the recent Zantac recall, investigations into those manufacturers can take place.

Zantac recall: FDA says do not take this medication

Ohio residents have reason to be concerned about N-Nitrosodimethylamine (NDMA). The Food and Drug Administration says that when this contaminant is an ingredient in certain medications, it may increase in impurity if left to sit on a shelf over time at temperatures higher than room temperature. NDMA is an ingredient in Zantac, a ranitidine medication. The FDA has issued a Zantac recall, warning that all over-the-counter and prescription ranitidine drugs should be immediately removed from the marketplace.

Zantac recall issues: Understanding the signs of breast cancer

The aftermath of the removal of certain over-the-counter heartburn medications continues to come to light. Recently, this blog highlighted some of the symptoms of prostate cancer as it relates to the use of medications containing ranitidine ("Zantac recall issues: Knowing the signs of prostate cancer, July 26, 2020"). This blog will take a look at some of the more common signs of breast cancer, which research indicates can also result from the use of these drugs.

Zantac recall issues: Knowing the signs of prostate cancer

Prior to the emergence of the current global situation, Ohio residents were watching for signs they suffered some medical harm due to medications containing ranitidine. Since the Zantac recall began, researchers began associating certain types of cancer with the use of this and other heartburn drugs sold both over the counter and by prescription. One type of cancer that men who used these drugs may want to watch for is prostate cancer.

Zantac use is now linked to breast and prostate cancer

In 2019, the United States Food and Drug Administration (FDA) announced that Zantac (ranitidine) contained a cancer-causing impurity, N-nitrosodimethylamine (NDMA). Since the announcement, additional information has become available further connecting this medication to an increased risk of more and more types of cancer.

The Zantac recall has limited options for heartburn sufferers

Any number of things such as stress, spicy foods and more can cause heartburn. Many people across the country and here in Ohio used to take medications containing ratinidine for this condition, which is the main ingredient in over-the-counter drugs such as Zantac. When the Zantac recall began, people were forced to find other options, and they continue to get smaller as options dwindle.

Nizatidine oral solution recalled for presence of NDMA

By now, most people here in Ohio have heard of the problem with heartburn medications containing rantidine, including Zantac. Testing indicates these medications contain unsafe levels of NDMA, which is a probable human carcinogen. Recently, the Food and Drug Administration ordered the recall of all rantidine products from the market. Now, yet another heartburn medication is being recalled due to the presence of NDMA.

Zantac recall for ranitidine grows to include another medication

People across the country and here in Ohio continue to suffer from gastrointestinal ailments such as ulcers and acid reflux despite the recent removal of medications containing ranitidine from the market. In the wake of the Zantac recall, people turned to other medications to deal with these ailments. The problem is that now people may have to find yet another alternative to treat these conditions due to the recall of yet another medication.

FDA announces complete ranitidine recall

In the midst of everything else going on here in Ohio and across the country, the Food and Drug Administration still has to fulfill its obligations to the public, which means keeping track of dangerous and defective products and medications. As part of this ongoing mission, the FDA recently announced that it requested all manufacturers to initiate an immediate and complete ranitidine recall. This would take all medications containing it off the market.

Ranitidine recalls continue, but don't get the press they need

Along with everyone else in the country, Ohio residents have bigger concerns than what is happening with heartburn medications. However, it is still important to keep up to date on ranitidine recalls, especially for those who are having issues due to stress. Some people may be surprised to learn that testing and the investigation into the presence of N-Nitrosodimethylamine, or NDMA, continues regardless of what else may be going on right now.

Awards & Recognition

Contact Us For A Free Case Evaluation

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Email Us For A Response